We are adding to our holding in Eli Lilly.
Cramer’s Investing Club: We are nibbling on this drug stock amid the broad market sell-off
Share This Story, Choose Your Platform!
About the Author: David Hilbern
Free Confidential Consultation
(405) 213-1919
